当前位置:首页 > 股票大全 > 依米康 300249 财务分析

依米康财务分析

整理编辑:168股票行情网www.gphq168.com    数据来源:互联网 经供参考

依米康(300249)利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入251,754,005.76801,275,214.06549,633,628.98331,275,322.86
营业总成本243,430,007.72913,148,851.48617,734,695.82385,796,715.06
营业利润5,085,013.22-265,277,556.35-113,373,494.12-57,944,491.02
利润总额5,128,013.2-267,505,596.28-114,485,472.1-64,015,770.47
净利润5,223,148.54-243,271,647.18-107,736,391.78-62,241,183.89
其他综合收益----
综合收益总额5,223,148.54-243,271,647.18-107,736,391.78-62,241,183.89
依米康(300249)资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计1,070,233,289.721,117,670,277.411,411,555,568.891,372,377,768.96
非流动资产合计504,847,433.27506,147,933.94722,746,497.63736,838,802.67
资产总计1,575,080,722.991,623,818,211.352,134,302,066.522,109,216,571.63
流动负债合计1,038,997,801.561,080,518,482.771,332,527,558.251,247,538,498.66
非流动负债合计113,826,119.14126,266,074.83144,575,919.15162,309,151.8
负债合计1,152,823,920.71,206,784,557.61,477,103,477.41,409,847,650.46
归属于母公司股东权益合计413,481,802.29408,258,653.75569,284,865.16599,876,382.68
股东权益合计422,256,802.29417,033,653.75657,198,589.12699,368,921.17
负债和股东权益合计1,575,080,722.991,623,818,211.352,134,302,066.522,109,216,571.63
依米康(300249)现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计171,104,048.67855,267,335.72486,387,233.98283,631,306
经营活动现金流出小计224,391,712.68976,252,482.45690,785,755.67451,844,902.4
经营活动产生的现金流量净额-53,287,664.01-120,985,146.73-204,398,521.69-168,213,596.4
投资活动现金流入小计-100,577,609.6879,246,189.356,746,189.3
投资活动现金流出小计21,3945,689,692.17576,000.82211,630.48
投资活动产生的现金流量净额-21,39494,887,917.5178,670,188.4856,534,558.82
筹资活动现金流入小计75,000,000342,057,819.68331,463,710.38261,826,818.13
筹资活动现金流出小计98,468,860.99356,700,812.02327,765,159.14266,122,866.18
筹资活动产生的现金流量净额-23,468,860.99-14,642,992.343,698,551.24-4,296,048.05
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-76,777,919-40,740,221.56-122,029,781.97-115,975,085.63
期末现金及现金等价物余额54,275,428.39131,053,347.3949,763,786.9855,818,483.32
依米康300249相关数据
今日股市大盘指数